Therapeutic gene editing of T cells to correct CTLA-4 insufficiency.


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
26 10 2022
Historique:
entrez: 26 10 2022
pubmed: 27 10 2022
medline: 29 10 2022
Statut: ppublish

Résumé

Heterozygous mutations in

Identifiants

pubmed: 36288278
doi: 10.1126/scitranslmed.abn5811
doi:

Substances chimiques

CTLA-4 Antigen 0
B7-2 Antigen 0
DNA, Complementary 0
Antigens, CD 0
B7-1 Antigen 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabn5811

Subventions

Organisme : Department of Health
Pays : United Kingdom
Organisme : Versus Arthritis
ID : 21738
Pays : United Kingdom
Organisme : Versus Arthritis
ID : 21147
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 216358/Z/19/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204798
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N001435/1
Pays : United Kingdom

Auteurs

Thomas Andrew Fox (TA)

UCL Institute of Immunity and Transplantation, University College London, London, NW3 2PP, UK.
Department of Haematology, University College London NHS Foundation Trust, London, NW1 2BU UK.
UCL Great Ormond Street Institute of Child Health, UCL, London WC1N 1EH, UK.

Benjamin Christopher Houghton (BC)

UCL Great Ormond Street Institute of Child Health, UCL, London WC1N 1EH, UK.

Lina Petersone (L)

UCL Institute of Immunity and Transplantation, University College London, London, NW3 2PP, UK.

Erin Waters (E)

UCL Institute of Immunity and Transplantation, University College London, London, NW3 2PP, UK.

Natalie Mona Edner (NM)

UCL Institute of Immunity and Transplantation, University College London, London, NW3 2PP, UK.

Alex McKenna (A)

UCL Institute of Immunity and Transplantation, University College London, London, NW3 2PP, UK.

Olivier Preham (O)

UCL Institute of Immunity and Transplantation, University College London, London, NW3 2PP, UK.

Claudia Hinze (C)

UCL Institute of Immunity and Transplantation, University College London, London, NW3 2PP, UK.

Cayman Williams (C)

UCL Institute of Immunity and Transplantation, University College London, London, NW3 2PP, UK.

Adriana Silva de Albuquerque (AS)

UCL Institute of Immunity and Transplantation, University College London, London, NW3 2PP, UK.
University College London Hospital, National Institute for Health and Care Research Biomedical Research Centre, London W1T 7DN, UK.

Alan Kennedy (A)

UCL Institute of Immunity and Transplantation, University College London, London, NW3 2PP, UK.

Anne Maria Pesenacker (AM)

UCL Institute of Immunity and Transplantation, University College London, London, NW3 2PP, UK.

Pietro Genovese (P)

Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Boston, MA 02115, USA.

Lucy Sarah Kate Walker (LSK)

UCL Institute of Immunity and Transplantation, University College London, London, NW3 2PP, UK.

Siobhan Oisin Burns (SO)

UCL Institute of Immunity and Transplantation, University College London, London, NW3 2PP, UK.
Department of Immunology, Royal Free London Hospitals NHS Foundation Trust, London, NW3 2QG, UK.

David Michael Sansom (DM)

UCL Institute of Immunity and Transplantation, University College London, London, NW3 2PP, UK.

Claire Booth (C)

UCL Great Ormond Street Institute of Child Health, UCL, London WC1N 1EH, UK.
Department of Paediatric Immunology, Great Ormond Street Hospital, London WC1N 3JH, UK.

Emma Catherine Morris (EC)

UCL Institute of Immunity and Transplantation, University College London, London, NW3 2PP, UK.
Department of Haematology, University College London NHS Foundation Trust, London, NW1 2BU UK.
University College London Hospital, National Institute for Health and Care Research Biomedical Research Centre, London W1T 7DN, UK.
Department of Immunology, Royal Free London Hospitals NHS Foundation Trust, London, NW3 2QG, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH